646.6K XNAS Volume
XNAS 20 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Clay B. Siegall | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 7.75 per share. | 31 Jan 2025 | 150,000 | 669,636 | - | 7.8 | 1,162,500 | Common Stock |
| Philip Tsai | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 9.43 per share. | 21 Nov 2024 | 21,000 | 21,000 | - | 9.4 | 198,030 | Common Stock |
| Robert Lechleider | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 9.48 per share. | 21 Nov 2024 | 15,805 | 15,805 | - | 9.5 | 149,800 | Common Stock |
| Clay B. Siegall | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.78 per share. | 21 Nov 2024 | 33,943 | 519,636 | - | 9.8 | 331,918 | Common Stock |
| Clay B. Siegall | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.54 per share. | 21 Nov 2024 | 66,057 | 485,693 | - | 9.5 | 630,263 | Common Stock |
| Max Rosett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 19 Sep 2024 | 14,380 | 47,476 | - | 16.0 | 230,224 | Common Stock |
| Max Rosett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Sep 2024 | 42,000 | 91,848 | - | - | Stock option (right to buy) | |
| Max Rosett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 19 Sep 2024 | 42,000 | 61,856 | - | 1.1 | 44,100 | Common Stock |
| Jack Higgins | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Aug 2024 | 2,471 | 13,529 | - | 0 | Common Stock | |
| Jack Higgins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 19,524 | 179,040 | - | - | Stock option (right to buy) | |
| Jack Higgins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.93 per share. | 15 Aug 2024 | 3,524 | 16,000 | - | 13.9 | 49,072 | Common Stock |
| Jack Higgins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.35 per share. | 15 Aug 2024 | 19,524 | 19,524 | - | 1.3 | 26,357 | Common Stock |
| Robert Lechleider | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Max Rosett | EVP, Operations & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 190,000 | 190,000 | - | - | Stock option (right to buy) | |
| Jack Higgins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 190,000 | 190,000 | - | - | Stock option (right to buy) | |
| Bruce Turner | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 110,000 | 110,000 | - | - | Stock option (right to buy) | |
| Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 130,000 | 130,000 | - | - | Stock option (right to buy) | |
| Sandra G. Stoneman | CHIEF LEGAL OFFICER & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 210,000 | 210,000 | - | - | Stock option (right to buy) | |
| Clay B. Siegall | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 800,000 | 800,000 | - | - | Stock option (right to buy) | |
| Philip Tsai | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 250,000 | 250,000 | - | - | Stock option (right to buy) | |
| Carol A. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) | |
| Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) | |
| James P. Boylan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) | |
| Isaac Barchas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) | |
| Sandra M. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) | |
| Clay B. Siegall | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 13.91 per share. | 20 May 2024 | 79,566 | 399,202 | - | 13.9 | 1,106,524 | Common Stock |
| Clay B. Siegall | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 13.78 per share. | 20 May 2024 | 20,434 | 419,636 | - | 13.8 | 281,548 | Common Stock |
| Max Rosett | EVP, Operations & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Sandra M. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 25,737 | 25,737 | - | - | Stock option (right to buy) | |
| Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 300,000 | 300,000 | - | - | Stock option (right to buy) | |
| G. Sandra Stoneman | CHIEF LEGAL OFFICER & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Rosett Max | EVP, OPERATIONS & INTERIM CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 175,000 | 175,000 | - | - | Stock option (right to buy) | |
| A. Schafer Carol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 32,934 | 32,934 | - | - | Stock option (right to buy) | |
| Phil Noland Roberts | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 275,000 | 275,000 | - | - | Stock option (right to buy) | |
| Jack Higgins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Matthew K. Robinson | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 58,000 | 58,000 | - | - | Stock Option (Right to Buy) | |
| Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 58,000 | 58,000 | - | - | Stock Option (Right to Buy) | |
| Dennis H. Giesing | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sandra G. Stoneman | General Counsel and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | |
| Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Purnanand D. Sarma | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 166,500 | 166,500 | - | - | Stock Option (Right to Buy) | |
| Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Richard A. Baron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| John L. LaMattina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Franklyn G Prendergast | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 15 Jan 2023 | 13,875 | 40,747 | - | 4 | 55,500 | Common Stock |
| Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 15 Jan 2023 | 8,750 | 406,147 | - | 4 | 35,000 | Common Stock |
| John L. LaMattina | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 15 Jan 2023 | 15,125 | 66,953 | - | 4 | 60,500 | Common Stock |
| Matthew K. Robinson | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Dennis H. Giesing | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Sandra G. Stoneman | General Counsel and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 43,000 | 43,000 | - | - | Stock Option (Right to Buy) | |
| Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Purnanand D. Sarma | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 121,000 | 121,000 | - | - | Stock Option (Right to Buy) | |
| Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Richard A. Baron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| John L. LaMattina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Franklyn G Prendergast | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Richard A. Baron | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.38 per share. | 18 Aug 2021 | 2,343 | 2,343 | - | 11.4 | 26,663 | Common Stock |
| Richard A. Baron | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2021 | 2,343 | 5,157 | - | - | Stock Option (Right to Buy) | |
| Franklyn G Prendergast | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Purnanand D. Sarma | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 93,354 | 93,354 | - | - | Stock Option (Right to Buy) | |
| John L. LaMattina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Richard A. Baron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Michael Widlitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Sandra G. Stoneman | General Counsel and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 16,609 | 16,609 | - | - | Stock Option (Right to Buy) | |
| Dennis H. Giesing | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 16,609 | 16,609 | - | - | Stock Option (Right to Buy) | |
| Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 16,609 | 16,609 | - | - | Stock Option (Right to Buy) | |
| Purnanand D. Sarma | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.41 per share. | 25 May 2021 | 10,500 | 10,500 | - | 18.4 | 193,305 | Common Stock |
| John L. LaMattina | Director | Purchase of securities on an exchange or from another person at price $ 18.44 per share. | 24 May 2021 | 338 | 46,726 | - | 18.4 | 6,233 | Common Stock |
| John L. LaMattina | Director | Purchase of securities on an exchange or from another person at price $ 18.58 per share. | 24 May 2021 | 5,102 | 51,828 | - | 18.6 | 94,795 | Common Stock |
| Philip Wagenheim | Director | Purchase of securities on an exchange or from another person at price $ 18.35 per share. | 24 May 2021 | 13,500 | 397,397 | - | 18.4 | 247,725 | Common Stock |
| Michael Lefenfeld | Director | Purchase of securities on an exchange or from another person at price $ 17.80 per share. | 24 May 2021 | 600 | 22,822 | - | 17.8 | 10,680 | Common Stock |
| Michael Lefenfeld | Director | Purchase of securities on an exchange or from another person at price $ 19.03 per share. | 24 May 2021 | 1,335 | 26,872 | - | 19.0 | 25,405 | Common Stock |
| Michael Lefenfeld | Director | Purchase of securities on an exchange or from another person at price $ 18.44 per share. | 24 May 2021 | 2,715 | 25,537 | - | 18.4 | 50,065 | Common Stock |
| Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Dennis H. Giesing | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Richard A. Baron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy)(1) | |
| Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Michael Widlitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Sandra G. Stoneman | Chief Legal Officer & Gen Coun | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 148,837 | 148,837 | - | - | Employee Stock Option (Right to Buy) | |
| John L. Lamattina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Michael Lefenfeld | Director | 06 Oct 2020 | 22,222 | 22,222 | - | - | Common Stock | ||
| Michael Lefenfeld | Director | 06 Oct 2020 | 22,222 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Michael Lefenfeld | Director | 06 Oct 2020 | 11,111 | 0 | - | - | Warrant (right to buy) | ||
| Michael Lefenfeld | Director | 06 Oct 2020 | 11,111 | 11,111 | - | - | Warrant (right to buy) | ||
| John L. Lamattina | Director | 06 Oct 2020 | 11,111 | 0 | - | - | Warrant (right to buy) | ||
| John L. Lamattina | Director | 06 Oct 2020 | 46,388 | 46,388 | - | - | Common Stock | ||
| John L. Lamattina | Director | 06 Oct 2020 | 46,388 | 0 | - | - | Series A Convertible Preferred Stock | ||
| John L. Lamattina | Director | 06 Oct 2020 | 11,111 | 11,111 | - | - | Warrant (right to buy) | ||
| Michael Widlitz | Director | 06 Oct 2020 | 51,315 | 51,315 | - | - | Common Stock | ||
| Michael Widlitz | Director | 06 Oct 2020 | 51,315 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Richard F. Fitzgerald | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 7,681 | 7,681 | - | - | Employee Stock Option (right to buy) | |
| Richard F. Fitzgerald | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 104,802 | 104,802 | - | - | Employee Stock Option (right to buy) |